Pixelgen Technologies: Funding, Investors & Team (Aug 2026)

Pixelgen Technologies AB was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs with a vision to bring a new spatial understanding to biology by developing tools to facilitate the mapping of cell surface proteins and their spatial inter-relationships. Life operates by the spatial orchestration of proteins and at Pixelgen we have developed Molecular Pixelation that analyses cell surface proteins in a completely new way. Using current technologies, there are limitations of light and taking images influencing how many proteins and how many samples that can be analysed concurrently. With molecular pixelation you can measure hundreds of proteins simultaneously and obtain the spatial mapping of these proteins on the cell surface. This will be valuable for the understanding of life by gaining insights into cellular activity, by better understanding what constitutes the difference between health and disease. Pixelgen is headquartered in Stockholm, Sweden.

Pixelgen Technologies has raised $6.0M across 1 round on record. The most recent is a Seed of $6.0M announced in Dec 2022.

Pixelgen Technologies' most recent funding round on record is a Seed of $6.0M, announced in Dec 2022.

Simon Fredriksson is listed as CEO at Pixelgen Technologies.

Pixelgen Technologies is based in Stockholm, Stockholms Lan, Sweden.

Pixelgen Technologies is in the 11-50 employee band.

Pixelgen Technologies' latest round of $6.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.